CRISPR Therapeutics CRSP Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from CRISPR Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's net margin?
- CRISPR Therapeutics (CRSP) reported net margin of -13,856.5% in Q1 2026.
- How has CRISPR Therapeutics's net margin changed year-over-year?
- CRISPR Therapeutics's net margin decreased by 1253.7% year-over-year, from -1,023.6% to -13,856.5%.
- What is the long-term trend for CRISPR Therapeutics's net margin?
- Over 3 years (2020 to 2025), CRISPR Therapeutics's net margin has grown at a -30.1% compound annual growth rate (CAGR), from -48,520.9% to -16,569.8%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.